These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33045355)

  • 21. Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance.
    Guducuoglu H; Gursoy NC; Yakupogullari Y; Parlak M; Karasin G; Sunnetcioglu M; Otlu B
    Microb Drug Resist; 2018 Sep; 24(7):966-972. PubMed ID: 29265963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):244-248. PubMed ID: 28842283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.
    Capone A; Giannella M; Fortini D; Giordano A; Meledandri M; Ballardini M; Venditti M; Bordi E; Capozzi D; Balice MP; Tarasi A; Parisi G; Lappa A; Carattoli A; Petrosillo N
    Clin Microbiol Infect; 2013 Jan; 19(1):E23-E30. PubMed ID: 23137235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Demirlenk YM; Gücer LS; Uçku D; Tanrıöver C; Akyol M; Kalay Z; Barçın E; Akcan RE; Can F; Gönen M; Ergönül Ö
    Eur J Clin Microbiol Infect Dis; 2022 May; 41(5):761-769. PubMed ID: 35303195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae.
    Naparstek L; Carmeli Y; Navon-Venezia S; Banin E
    J Antimicrob Chemother; 2014 Apr; 69(4):1027-34. PubMed ID: 24408988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
    Cojutti P; Sartor A; Bassetti M; Scarparo C; Pea F
    J Glob Antimicrob Resist; 2018 Sep; 14():238-241. PubMed ID: 29775786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
    Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
    BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
    Monaco M; Giani T; Raffone M; Arena F; Garcia-Fernandez A; Pollini S; ; Grundmann H; Pantosti A; Rossolini GM
    Euro Surveill; 2014 Oct; 19(42):. PubMed ID: 25358041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case report of brain abscess caused by carbapenem-resistant Klebsiella pneumoniae.
    Tunckale T; Kavak C; Safak B; Gonen A; Erdem I
    Rev Inst Med Trop Sao Paulo; 2023; 65():e23. PubMed ID: 36995876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.
    Machuca I; Gutiérrez-Gutiérrez B; Rivera-Espinar F; Cano A; Gracia-Ahufinger I; Guzman-Puche J; Marfil-Pérez E; Pérez-Nadales E; Castón JJ; Bonomo RA; Carmeli Y; Paterson D; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J;
    Int J Antimicrob Agents; 2019 Oct; 54(4):442-448. PubMed ID: 31377343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem non-susceptibility of
    Koppe U; von Laer A; Kroll LE; Noll I; Feig M; Schneider M; Claus H; Eckmanns T; Abu Sin M
    Antimicrob Resist Infect Control; 2018; 7():71. PubMed ID: 29992016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.
    Poudyal A; Howden BP; Bell JM; Gao W; Owen RJ; Turnidge JD; Nation RL; Li J
    J Antimicrob Chemother; 2008 Dec; 62(6):1311-8. PubMed ID: 18922815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.
    Simitsopoulou M; Chlichlia K; Kyrpitzi D; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification.
    Avendaño-Ortiz J; Ponce-Alonso M; Llanos-González E; Barragán-Prada H; Barbero-Herranz R; Lozano-Rodríguez R; Márquez-Garrido FJ; Hernández-Pérez JM; Morosini MI; Cantón R; Del Campo R; López-Collazo E
    Infect Immun; 2023 Feb; 91(2):e0001223. PubMed ID: 36722977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.
    Varotti G; Dodi F; Terulla A; Santori G; Mariottini G; Bertocchi M; Marchese A; Fontana I
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28796391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.